Reckitt Cuts 2026 Growth Outlook After Lysol Constraints

Reckitt lowered its 2026 Core Reckitt revenue-growth outlook to 3.5%–4.5% from 4%–5% after third-quarter like-for-like growth of 3.3% fell short of analyst expectations. North American revenue declined 1.3% as temporary manufacturing constraints limited Lysol supply despite strong demand; weaker seasonal self-care sales and retailer order timing also weighed on the region. Emerging Markets grew strongly, while Europe returned to modest growth. A slowdown in China’s vitamins and supplements category added pressure to the outlook. Reckitt maintained its adjusted operating-margin guidance and medium-term goal of 4%–5% annual revenue growth.